Actinium Pharmaceuticals Presents New Preclinical Data From Its ATNM-400 Across Non-Small Cell Lung Cancer At 39th Annual Congress Of European Association Of Nuclear Medicine

Benzinga

2026.10.20 11:32 (GMT+0)

Öffnen unter Benzinga